tirzepatide and sibo Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study Tirzepatide reduces food intake and

It is often recommended for individuals with obesity or those experiencing weight-related health concerns, such as insulin resistance or metabolic challenges

What is the cost of the therapy

The MHRA has confirmed seizures made at a Northamptonshire country house, last week as well as those in February 2026 in Lincolnshire and Nottingham are connected and part of its "ongoing investigation into an organised criminal network"

In the Novo Nordisk-funded study, published on 22 October 2025, researchers from University College London (UCL) analysed data from the SELECT trial (published in 2023) of 17,604 people from 41 countries aged 45 years and over, who were overweight and had cardiovascular disease (CVD) but did not have diabetes

But the cracks show quickly

Many patients wonder whether this appetite suppression means they can eat anything and still lose weight, or whether deliberate food choices matter for lasting success